|
Aug 28
|
LifeNet launches newest bone allograft gel with Johnson & Johnson
|
|
Aug 12
|
BBLG: Controls Costs and Advances Trials
|
|
Jun 21
|
Life Science Virtual Investor Forum Presentations Now Available for Online Viewing
|
|
Jun 20
|
First patients treated in Bone Biologics spinal fusion trial
|
|
Jun 20
|
First Two Patients Treated in Pilot Clinical Study with Bone Biologics’ NB1 Bone Graft Device in Spine Fusion
|
|
Jun 20
|
BBLG Marks Important Milestone
|
|
May 16
|
BBLG Continues Progress as Testing Proceeds
|
|
Jan 11
|
Bone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of Directors
|
|
Jan 10
|
Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements
|
|
Dec 20
|
BBLG Announces Split as Pursuit of Breakthrough Treatment Continues
|
|
Dec 18
|
Bone Biologics Announces 1-for-8 Reverse Stock Split
|
|
Sep 26
|
Bone Biologics Provides Scientific Update on NB1 Bone Graft Device
|